FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

ANDA 'Refuse-to-receive' Actions Double Since 2009

[ Price : $8.95]

CDER Office of Generic Drugs regulatory support manager Kwadwo Awuah says incomplete ANDA applications that are refused to be acce...

Info on In Vivo Radiopharmaceuticals Sent to OMB

[ Price : $8.95]

Federal Register Notice: FDA submits a proposed collection of information on regulations for in vivo radiopharmaceuticals used for...

FDA Debars Martinez Seldon

[ Price : $8.95]

Federal Register Notice: FDA permanently debars Deborah Martinez Seldon from providing services to anyone with an approved or pend...

Ex-Synthes Execs Sentencing Next Month

[ Price : $8.95]

A federal court sets sentencing for four former Synthes executives, each of whom pleaded guilty to a misdemeanor charge stemming f...

FDA Releases Biomedical Innovation Blueprint

[ Price : $8.95]

FDA commissioner Margaret Hamburg releases the agencys blueprint for driving medical product innovation.

Boston Scientific Begins OMEGA Trial Enrollment

[ Price : $8.95]

Boston Scientific Corp. begins enrolling patients in the OMEGA trial to evaluate the safety and effectiveness of its OMEGA Platinu...

FDA Declares Certain Preemption Statements Not Justified

[ Price : $8.95]

Federal Register Notification of preemption review: FDA determines that three FDA regulatory preambles refer to preemption stateme...

Comments Sought on Animal Generic Drug User Fee Form

[ Price : $8.95]

Federal Register Notice: FDA seeks comments on the information collection burden of the Animal Generic Drug User Fee Cover Sheet f...

Panel to Discuss Pediatric Use for 4 Oncology Products

[ Price : $8.95]

Federal Register Notice: FDAs Pediatric Oncology Subcommittee will meet to discuss pediatric development plans for four approved p...

FDA Finishes Inspection of Apicore India Plant

[ Price : $8.95]

FDA completes its initial inspection of Apicores API manufacturing facility in India.